Test Price
900 AED✅ Home Collection Available
Choclo Virus RNA Detection Test in Dubai | 900 AED | Real-Time PCR
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% diagnostic sensitivity via ISO 15189 accredited Real-Time PCR methodology for early viral RNA detection.
- Collection Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Post-test telephone consultation provided for result interpretation and clinical correlation.
- Insurance Verification: Direct insurance coverage check via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Choclo Virus RNA Qualitative Test employs Real-Time Polymerase Chain Reaction (qPCR) to detect viral RNA responsible for Hantavirus Pulmonary Syndrome (HPS). This molecular technique amplifies specific genetic sequences of the Choclo orthohantavirus, enabling early and accurate diagnosis before seroconversion occurs. Optional Whole Genome Sequencing (WGS) confirmation is available for epidemiological surveillance and variant characterization.
| Feature | Our Test (Real-Time PCR) | Closest Alternative (Serology) |
|---|---|---|
| Technology | Real-Time PCR (qPCR) with optional WGS confirmation | ELISA IgM/IgG |
| Diagnostic Sensitivity | >99.9% (viral RNA detection) | 80–90% (antibody-dependent window) |
| Turnaround Time | 3 working days (24‑hour phone alert available) | 5–7 working days |
| Sample Types | EDTA whole blood, serum, plasma, BAL, CSF, urine | Blood (serum) only |
| Detects Active Infection | Yes (within 1–7 days of symptom onset) | No (requires seroconversion, usually after 7–14 days) |
| Price | 900 AED | 450–600 AED |
Physician Insight & Safety Protocols
"Real-Time PCR detection of Choclo virus RNA offers the highest diagnostic sensitivity during the acute viremic phase of Hantavirus Pulmonary Syndrome. A positive result confirms viral RNA presence and should prompt immediate clinical management. However, a negative result collected within the first 48 hours of fever does not exclude infection; repeat testing or serological correlation may be warranted. Results must always be interpreted within the complete clinical context including travel history, exposure risk, and symptom progression."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403Advisory Protocol & Clinical Precautions
Important Clinical Advisory
- Medication Advisory: Do not discontinue prescribed medication without consulting your doctor.
- Testing Window: Optimal sample collection occurs within 1–7 days of symptom onset. Samples collected during the first 48 hours of fever may yield false negative results.
- Clinical Correlation: A positive result must be correlated with clinical symptoms, travel history to endemic areas, and known exposure history.
Exclusion Criteria & Emergency Red Flags
Contraindications & Urgent Warning Signs
- Exclusion: Inability to provide informed consent; severe coagulopathy that precludes safe blood draw or invasive respiratory sampling.
- Red Flags: Seek immediate emergency care if you experience sudden shortness of breath, chest tightness, confusion, drop in blood pressure, or reduced urine output—these may indicate severe HPS or HFRS.
- Sample Requirements: For suspected HPS, bronchial lavage or serum during viremia is optimal. For HFRS, urine is the preferred specimen. A signed consent form and clinical history are mandatory prior to collection.
Patient FAQ & Clinical Guidance
1. How soon after exposure can the Choclo Virus RNA test detect infection?
With a diagnostic sensitivity of 99.9%, this Real-Time PCR can detect viral RNA as early as 2–4 days post‑exposure, often before antibodies develop. Testing during the prodromal phase (fever, myalgia) maximizes accuracy. A negative result does not rule out infection if the sample was collected outside the viremic window; repeat PCR or serology may be advised.
2. Why is sample collection restricted to hospital settings?
This test accepts specimen types including bronchoalveolar lavage (BAL) and cerebrospinal fluid (CSF), both of which require invasive clinical procedures that must be performed within an accredited hospital facility. For patient safety and specimen integrity, all collections are conducted under strict medical supervision. Peripheral blood and urine samples are also accepted and collected in the same hospital setting.
3. What preparation is required before the test?
No fasting is required, but you must sign an informed consent form and present your full medical history for accurate interpretation. If you are on anticoagulants, inform the attending clinician before sample collection. A signed consent form and documented clinical history are mandatory prior to specimen collection.
4. How are results delivered and what follow-up is provided?
Results are available within 3 working days, with a 24‑hour phone alert option for urgent cases. A post-test telephone consultation is provided by our clinical team to interpret results and recommend next steps. All results are delivered securely in compliance with UAE data protection regulations.
UAE Regulatory & Data Privacy Adherence
All clinical data and patient information are processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
DNA Labs UAE operates under DHA Facility License No. 1143, ensuring the highest standards of data security, patient confidentiality, and clinical governance in accordance with Dubai Healthcare City Authority regulations.
Clinical & Logistical Metadata
| Test Name | Choclo Virus RNA Detection Test (Real-Time PCR) |
| Price (AED) | 900 |
| Turnaround Time | 3 working days (24‑hour phone alert available) |
| Sample Type / Matrix | EDTA whole blood, serum, plasma, BAL, CSF, urine – Hospital Extraction Only |
| Methodology Used | Real-Time PCR (qPCR) with optional Whole Genome Sequencing confirmation |
| ICD-10-CM Code | B33.4 |
| LOINC Code | 88523-5 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians